These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 29169370)
1. Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop. Thakur B; Ray P J Exp Clin Cancer Res; 2017 Nov; 36(1):164. PubMed ID: 29169370 [TBL] [Abstract][Full Text] [Related]
2. p53 Loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance. Thakur B; Ray P Mol Oncol; 2016 Oct; 10(8):1283-95. PubMed ID: 27401370 [TBL] [Abstract][Full Text] [Related]
3. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways. Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513 [TBL] [Abstract][Full Text] [Related]
4. Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma. Chen X; Cao Y; Sedhom W; Lu L; Liu Y; Wang H; Oka M; Bornstein S; Said S; Song J; Lu SL Mol Oncol; 2020 Jan; 14(1):139-158. PubMed ID: 31600013 [TBL] [Abstract][Full Text] [Related]
5. Cisplatin induces stemness in ovarian cancer. Wiechert A; Saygin C; Thiagarajan PS; Rao VS; Hale JS; Gupta N; Hitomi M; Nagaraj AB; DiFeo A; Lathia JD; Reizes O Oncotarget; 2016 May; 7(21):30511-22. PubMed ID: 27105520 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Wang D; Fu L; Sun H; Guo L; DuBois RN Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008 [TBL] [Abstract][Full Text] [Related]
7. KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma. Wang B; Jing T; Jin W; Chen J; Wu C; Wang M; Liu Y J Exp Clin Cancer Res; 2020 Aug; 39(1):170. PubMed ID: 32854746 [TBL] [Abstract][Full Text] [Related]
8. miR‑10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K/Akt pathway. Huang T; Ren K; Ding G; Yang L; Wen Y; Peng B; Wang G; Wang Z Oncol Rep; 2020 Jun; 43(6):1906-1914. PubMed ID: 32186774 [TBL] [Abstract][Full Text] [Related]
9. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC. Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871 [TBL] [Abstract][Full Text] [Related]
10. NF-kappaB activation is required for cisplatin-induced apoptosis in head and neck squamous carcinoma cells. Kim SB; Kim JS; Lee JH; Yoon WJ; Lee DS; Ko MS; Kwon BS; Choi DH; Cho HR; Lee BJ; Chung DK; Lee HW; Park JW FEBS Lett; 2006 Jan; 580(1):311-8. PubMed ID: 16376337 [TBL] [Abstract][Full Text] [Related]
11. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells. Arjumand W; Merry CD; Wang C; Saba E; McIntyre JB; Fang S; Kornaga E; Ghatage P; Doll CM; Lees-Miller SP Oncotarget; 2016 Dec; 7(50):82424-82439. PubMed ID: 27489350 [TBL] [Abstract][Full Text] [Related]
12. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells. Benedetti G; Fredriksson L; Herpers B; Meerman J; van de Water B; de Graauw M Biochem Pharmacol; 2013 Jan; 85(2):274-86. PubMed ID: 23103562 [TBL] [Abstract][Full Text] [Related]
13. NF-κB-regulated miR-155, via repression of QKI, contributes to the acquisition of CSC-like phenotype during the neoplastic transformation of hepatic cells induced by arsenite. Chen C; Luo F; Yang Q; Wang D; Yang P; Xue J; Dai X; Liu X; Xu H; Lu J; Zhang A; Liu Q Mol Carcinog; 2018 Apr; 57(4):483-493. PubMed ID: 29240254 [TBL] [Abstract][Full Text] [Related]
14. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway. He S; Niu G; Shang J; Deng Y; Wan Z; Zhang C; You Z; Shen H J Exp Clin Cancer Res; 2017 Oct; 36(1):137. PubMed ID: 28978336 [TBL] [Abstract][Full Text] [Related]
15. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer. Wilson AJ; Saskowski J; Barham W; Yull F; Khabele D J Ovarian Res; 2015 Jul; 8():46. PubMed ID: 26215403 [TBL] [Abstract][Full Text] [Related]
16. Up-regulation of OLR1 expression by TBC1D3 through activation of TNFα/NF-κB pathway promotes the migration of human breast cancer cells. Wang B; Zhao H; Zhao L; Zhang Y; Wan Q; Shen Y; Bu X; Wan M; Shen C Cancer Lett; 2017 Nov; 408():60-70. PubMed ID: 28844714 [TBL] [Abstract][Full Text] [Related]
17. An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population. Singh RK; Dhadve A; Sakpal A; De A; Ray P Sci Rep; 2016 Nov; 6():36612. PubMed ID: 27819360 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNFα-induced apoptosis. Lee JH; Kang MJ; Han HY; Lee MG; Jeong SI; Ryu BK; Ha TK; Her NG; Han J; Park SJ; Lee KY; Kim HJ; Chi SG Clin Cancer Res; 2011 Dec; 17(24):7551-62. PubMed ID: 21980136 [TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis. Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320 [TBL] [Abstract][Full Text] [Related]
20. The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis. Baritaki S; Militello L; Malaponte G; Spandidos DA; Salcedo M; Bonavida B Int J Oncol; 2011 Jun; 38(6):1683-94. PubMed ID: 21455568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]